 This study will evaluate the safety of and immune responses to a dendritic cell vaccination for HIV-1 infection. The vaccine will be made from a patients own cells combined with small fragments of HIV-1 made synthetically in a laboratory. These cells will be administered back to the patient either into a vein intravenously or the skin subcutaneously. 